These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 7679748

  • 1. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4.
    Gavioli R, Kurilla MG, de Campos-Lima PO, Wallace LE, Dolcetti R, Murray RJ, Rickinson AB, Masucci MG.
    J Virol; 1993 Mar; 67(3):1572-8. PubMed ID: 7679748
    [Abstract] [Full Text] [Related]

  • 2. T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues.
    de Campos-Lima PO, Levitsky V, Brooks J, Lee SP, Hu LF, Rickinson AB, Masucci MG.
    J Exp Med; 1994 Apr 01; 179(4):1297-305. PubMed ID: 7511684
    [Abstract] [Full Text] [Related]

  • 3. Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides.
    Reali E, Guerrini R, Giori B, Borghi M, Marastoni M, Tomatis R, Traniello S, Masucci MG, Gavioli R.
    Clin Exp Immunol; 1996 Aug 01; 105(2):369-75. PubMed ID: 8706347
    [Abstract] [Full Text] [Related]

  • 4. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4.
    Levitsky V, Zhang QJ, Levitskaya J, Masucci MG.
    J Exp Med; 1996 Mar 01; 183(3):915-26. PubMed ID: 8642295
    [Abstract] [Full Text] [Related]

  • 5. An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins.
    Zhang QJ, Gavioli R, Klein G, Masucci MG.
    Proc Natl Acad Sci U S A; 1993 Mar 15; 90(6):2217-21. PubMed ID: 8384718
    [Abstract] [Full Text] [Related]

  • 6. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG, Zhang QJ, Gavioli R, De Campos-Lima PO, Murray RJ, Brooks J, Griffin H, Ploegh H, Rickinson AB.
    Int Immunol; 1992 Nov 15; 4(11):1283-92. PubMed ID: 1282031
    [Abstract] [Full Text] [Related]

  • 7. HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population.
    de Campos-Lima PO, Gavioli R, Zhang QJ, Wallace LE, Dolcetti R, Rowe M, Rickinson AB, Masucci MG.
    Science; 1993 Apr 02; 260(5104):98-100. PubMed ID: 7682013
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.
    Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, Kurilla MG, Masucci MG.
    Nature; 1995 Jun 22; 375(6533):685-8. PubMed ID: 7540727
    [Abstract] [Full Text] [Related]

  • 9. HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences.
    Midgley RS, Bell AI, Yao QY, Croom-Carter D, Hislop AD, Whitney BM, Chan AT, Johnson PJ, Rickinson AB.
    J Virol; 2003 Nov 22; 77(21):11507-16. PubMed ID: 14557636
    [Abstract] [Full Text] [Related]

  • 10. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide.
    Brooks JM, Murray RJ, Thomas WA, Kurilla MG, Rickinson AB.
    J Exp Med; 1993 Sep 01; 178(3):879-87. PubMed ID: 7688791
    [Abstract] [Full Text] [Related]

  • 11. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.
    Gavioli R, De Campos-Lima PO, Kurilla MG, Kieff E, Klein G, Masucci MG.
    Proc Natl Acad Sci U S A; 1992 Jul 01; 89(13):5862-6. PubMed ID: 1321426
    [Abstract] [Full Text] [Related]

  • 12. Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes.
    Pepperl S, Benninger-Döring G, Modrow S, Wolf H, Jilg W.
    J Virol; 1998 Nov 01; 72(11):8644-9. PubMed ID: 9765404
    [Abstract] [Full Text] [Related]

  • 13. Cross-recognition of a mouse H-2-peptide complex by human HLA-restricted cytotoxic T cells.
    Murray RJ, Brooks JM, Rickinson AB, Rowe M.
    Eur J Immunol; 1990 Mar 01; 20(3):659-64. PubMed ID: 1690661
    [Abstract] [Full Text] [Related]

  • 14. Epstein-Barr virus isolates with the major HLA B35.01-restricted cytotoxic T lymphocyte epitope are prevalent in a highly B35.01-positive African population.
    Lee SP, Morgan S, Skinner J, Thomas WA, Jones SR, Sutton J, Khanna R, Whittle HC, Rickinson AB.
    Eur J Immunol; 1995 Jan 01; 25(1):102-10. PubMed ID: 7531142
    [Abstract] [Full Text] [Related]

  • 15. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
    Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ.
    J Exp Med; 1992 Jul 01; 176(1):169-76. PubMed ID: 1377222
    [Abstract] [Full Text] [Related]

  • 16. HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.
    Lee SP, Thomas WA, Murray RJ, Khanim F, Kaur S, Young LS, Rowe M, Kurilla M, Rickinson AB.
    J Virol; 1993 Dec 01; 67(12):7428-35. PubMed ID: 7693972
    [Abstract] [Full Text] [Related]

  • 17. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.
    Khanna R, Burrows SR, Steigerwald-Mullen PM, Thomson SA, Kurilla MG, Moss DJ.
    Virology; 1995 Dec 20; 214(2):633-7. PubMed ID: 8553567
    [Abstract] [Full Text] [Related]

  • 18. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
    Hill AB, Lee SP, Haurum JS, Murray N, Yao QY, Rowe M, Signoret N, Rickinson AB, McMichael AJ.
    J Exp Med; 1995 Jun 01; 181(6):2221-8. PubMed ID: 7539044
    [Abstract] [Full Text] [Related]

  • 19. The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T-lymphocyte responses.
    Micheletti F, Bazzaro M, Canella A, Marastoni M, Traniello S, Gavioli R.
    Immunology; 1999 Mar 01; 96(3):411-5. PubMed ID: 10233722
    [Abstract] [Full Text] [Related]

  • 20. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein.
    Couillin I, Culmann-Penciolelli B, Gomard E, Choppin J, Levy JP, Guillet JG, Saragosti S.
    J Exp Med; 1994 Sep 01; 180(3):1129-34. PubMed ID: 7520468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.